These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30630117)

  • 1. Renal disease in Cockayne syndrome.
    Stern-Delfils A; Spitz MA; Durand M; Obringer C; Calmels N; Olagne J; Pillay K; Fieggen K; Laugel V; Zaloszyc A
    Eur J Med Genet; 2020 Jan; 63(1):103612. PubMed ID: 30630117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cockayne syndrome with recurrent acute tubulointerstitial nephritis.
    Funaki S; Takahashi S; Murakami H; Harada K; Kitamura H
    Pathol Int; 2006 Nov; 56(11):678-82. PubMed ID: 17040291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].
    Jovanović DB; Jovović Dj; Varagić J; Dimitrijević J; Dragojlović Z; Djukanović L
    Srp Arh Celok Lek; 2002; 130(3-4):73-80. PubMed ID: 12154518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephrotic syndrome, hypertension, and adrenal failure in atypical Cockayne syndrome.
    Reiss U; Hofweber K; Herterich R; Waldherr R; Bohnert E; Jung E; Schärer K
    Pediatr Nephrol; 1996 Oct; 10(5):602-5. PubMed ID: 8897565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine?
    Ahmed A
    J Am Geriatr Soc; 2002 Jul; 50(7):1297-300. PubMed ID: 12133029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibitors in chronic renal failure.
    Opsahl JA; Abraham PA; Keane WF
    Drugs; 1990; 39 Suppl 2():23-32. PubMed ID: 2188823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated Urinary Levels of 8-Hydroxy-2'-deoxyguanosine in a Japanese Child of Xeroderma Pigmentosum/Cockayne Syndrome Complex with Infantile Onset of Nephrotic Syndrome.
    Kondo D; Noguchi A; Tamura H; Tsuchida S; Takahashi I; Kubota H; Yano T; Oyama C; Sawaishi Y; Moriwaki S; Takahashi T
    Tohoku J Exp Med; 2016 Jul; 239(3):231-5. PubMed ID: 27396511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal Involvement in 2 Siblings With Cockayne Syndrome.
    Ben Chehida A; Ghali N; Ben Abdelaziz R; Ben Moussa F; Tebib N
    Iran J Kidney Dis; 2017 May; 11(3):253-255. PubMed ID: 28575888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndrome.
    Ruggenenti P; Mosconi L; Vendramin G; Moriggi M; Remuzzi A; Sangalli F; Remuzzi G
    Am J Kidney Dis; 2000 Mar; 35(3):381-91. PubMed ID: 10692263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conservative management of chronic kidney disease stage 5: role of angiotensin converting enzyme inhibitors.
    Dattolo PC; Gallo P; Michelassi S; Paudice N; Cannavò R; Romoli E; Fani F; Tsalouchos A; Mehmetaj A; Ferro G; Sisca S; Pizzarelli F
    J Nephrol; 2016 Dec; 29(6):809-815. PubMed ID: 27015900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strict blood-pressure control and progression of renal failure in children.
    ; Wühl E; Trivelli A; Picca S; Litwin M; Peco-Antic A; Zurowska A; Testa S; Jankauskiene A; Emre S; Caldas-Afonso A; Anarat A; Niaudet P; Mir S; Bakkaloglu A; Enke B; Montini G; Wingen AM; Sallay P; Jeck N; Berg U; Caliskan S; Wygoda S; Hohbach-Hohenfellner K; Dusek J; Urasinski T; Arbeiter K; Neuhaus T; Gellermann J; Drozdz D; Fischbach M; Möller K; Wigger M; Peruzzi L; Mehls O; Schaefer F
    N Engl J Med; 2009 Oct; 361(17):1639-50. PubMed ID: 19846849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arterial hypertension treated with angiotensin converting enzyme inhibitors and glucocorticoids are independent risk factors associated with decreased glomerular filtration rate in systemic sclerosis.
    Ostojic P; Stojanovski N
    Rheumatol Int; 2017 Mar; 37(3):363-368. PubMed ID: 28008457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dense deposit disease: clinicopathologic study of 32 pediatric and adult patients.
    Nasr SH; Valeri AM; Appel GB; Sherwinter J; Stokes MB; Said SM; Markowitz GS; D'Agati VD
    Clin J Am Soc Nephrol; 2009 Jan; 4(1):22-32. PubMed ID: 18971369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal 25-Hydroxyvitamin D Levels Are Associated with Less Proteinuria and Attenuate Renal Failure Progression in Children with CKD.
    Shroff R; Aitkenhead H; Costa N; Trivelli A; Litwin M; Picca S; Anarat A; Sallay P; Ozaltin F; Zurowska A; Jankauskiene A; Montini G; Charbit M; Schaefer F; Wühl E;
    J Am Soc Nephrol; 2016 Jan; 27(1):314-22. PubMed ID: 26069294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Change in proteinuria after adding aldosterone blockers to ACE inhibitors or angiotensin receptor blockers in CKD: a systematic review.
    Bomback AS; Kshirsagar AV; Amamoo MA; Klemmer PJ
    Am J Kidney Dis; 2008 Feb; 51(2):199-211. PubMed ID: 18215698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme inhibition in nondiabetic progressive renal insufficiency: a controlled double-blind trial.
    Ihle BU; Whitworth JA; Shahinfar S; Cnaan A; Kincaid-Smith PS; Becker GJ
    Am J Kidney Dis; 1996 Apr; 27(4):489-95. PubMed ID: 8678058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACE inhibitors and the kidney. A risk-benefit assessment.
    Navis G; Faber HJ; de Zeeuw D; de Jong PE
    Drug Saf; 1996 Sep; 15(3):200-11. PubMed ID: 8879974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury.
    Ruggenenti P; Perna A; Gherardi G; Benini R; Remuzzi G
    Am J Kidney Dis; 2000 Jun; 35(6):1155-65. PubMed ID: 10845831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An observational study of outcome in SLE patients with biopsy-verified glomerulonephritis between 1986 and 2004 in a defined area of southern Sweden: the clinical utility of the ACR renal response criteria and predictors for renal outcome.
    Nived O; Hallengren CS; Alm P; Jönsen A; Sturfelt G; Bengtsson AA
    Scand J Rheumatol; 2013; 42(5):383-9. PubMed ID: 23829689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.